| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |